Prudential Financial’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
Prudential Financial's TPTX Position: Q3 2022 in Review
Prudential Financial sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 13,266 shares — an estimated $998K sold.
Prudential Financial first reported a position in TPTX in Q3 2019 and held it in 11 quarters. The position peaked at $5.51M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.
- Prudential Financial reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Prudential Financial sold 13,266 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $998K.
- Prudential Financial first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 11 quarters.
- Prudential Financial's Turning Point Therapeutics, Inc. Common Stock position peaked at $5.51M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.
Based on Prudential Financial's 13F filing for Q3 2022, filed 4 Nov 2022.